Pay in 4 interest-free payments of $6.75 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
BPC-157 is not an FDA-approved drug in the United States or in most other jurisdictions worldwide
Spacing doses by 1-2 hours and working with your provider to monitor efficacy is medically necessary
Patient Testimonials: Many individuals report reduced pain and enhanced mobility following BPC-157 treatment
Systemic Implications If an 85 mg/day human protocol were sustained over 8 weeks to match the murine intranasal timeline, it would cross into a biochemically hazardous profile: Hepatic Accumulation: The primary adverse effect of chronic copper toxicity is hepatotoxicity
US$ 25.22
US$ 27.66
US$ 24.86
US$ 28.51
